Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.

Puhua Wu,Jiong Zhang,Qingqing Meng,Bakela Nare,Robert T Jacobs,Huchen Zhou
DOI: https://doi.org/10.1016/j.ejmech.2014.04.079
IF: 7.088
2014-01-01
European Journal of Medicinal Chemistry
Abstract:Human African trypanosomiasis is a fatal parasitic infection caused by the protozoan Trypanosoma brucei. The development of novel antitrypanosomal agents is urgently needed. Here we report the synthesis and structure–activity relationship of a new class of benzoxaboroles as antitrypanosomal agents. These compounds showed antiparasitic IC50 values ranging from 4.02 to 0.03 μg/mL and satisfactory cytotoxicity profile. Three of the lead compounds were demonstrated to cure the parasitic infection in a murine acute infection model. The structure–activity relationship of the pyrrolobenzoxaboroles are also discussed.
What problem does this paper attempt to address?